Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Malaria | 4 | 2020 | 1097 | 0.63 | Why? |
| Antimalarials | 6 | 2020 | 2505 | 0.61 | Why? |
| Malaria, Falciparum | 4 | 2017 | 377 | 0.49 | Why? |
| Poverty | 1 | 2020 | 2302 | 0.36 | Why? |
| Poultry | 1 | 2009 | 437 | 0.35 | Why? |
| Artemisinins | 4 | 2017 | 238 | 0.35 | Why? |
| Developing Countries | 2 | 2020 | 4283 | 0.34 | Why? |
| Mass Drug Administration | 2 | 2017 | 143 | 0.32 | Why? |
| Influenza A Virus, H5N1 Subtype | 1 | 2009 | 492 | 0.30 | Why? |
| Plasmodium falciparum | 3 | 2017 | 337 | 0.30 | Why? |
| Influenza in Birds | 1 | 2009 | 528 | 0.27 | Why? |
| Surge Capacity | 2 | 2021 | 894 | 0.25 | Why? |
| Immunity, Herd | 2 | 2020 | 1011 | 0.24 | Why? |
| Vaccines | 1 | 2021 | 3692 | 0.23 | Why? |
| Reverse Transcriptase Inhibitors | 1 | 2002 | 309 | 0.21 | Why? |
| Health Planning Guidelines | 1 | 2021 | 133 | 0.21 | Why? |
| Ethanolamines | 1 | 2017 | 71 | 0.17 | Why? |
| Host-Parasite Interactions | 1 | 2017 | 112 | 0.17 | Why? |
| Fluorenes | 1 | 2017 | 101 | 0.16 | Why? |
| Global Health | 2 | 2020 | 13911 | 0.16 | Why? |
| Models, Theoretical | 6 | 2021 | 6659 | 0.15 | Why? |
| Case Management | 1 | 2017 | 285 | 0.14 | Why? |
| Contact Tracing | 5 | 2021 | 8448 | 0.11 | Why? |
| Pandemics | 13 | 2021 | 389249 | 0.10 | Why? |
| Drug Therapy, Combination | 3 | 2017 | 7268 | 0.10 | Why? |
| Cambodia | 1 | 2009 | 190 | 0.10 | Why? |
| Anti-HIV Agents | 1 | 2002 | 2209 | 0.10 | Why? |
| Pneumonia, Viral | 9 | 2020 | 243684 | 0.09 | Why? |
| Patient Compliance | 1 | 2017 | 1468 | 0.09 | Why? |
| Insecticides | 2 | 2020 | 178 | 0.08 | Why? |
| Coronavirus Infections | 9 | 2020 | 253789 | 0.08 | Why? |
| HIV-1 | 1 | 2002 | 3365 | 0.08 | Why? |
| Severe Acute Respiratory Syndrome | 6 | 2006 | 12361 | 0.08 | Why? |
| Public Health | 3 | 2021 | 16359 | 0.08 | Why? |
| Health Services Needs and Demand | 1 | 2021 | 3419 | 0.08 | Why? |
| Humans | 34 | 2021 | 930598 | 0.08 | Why? |
| Mathematics | 2 | 2003 | 65 | 0.07 | Why? |
| HIV Infections | 2 | 2020 | 11620 | 0.07 | Why? |
| Health Services Accessibility | 2 | 2020 | 10697 | 0.07 | Why? |
| England | 3 | 2021 | 5116 | 0.07 | Why? |
| Hospitals | 2 | 2021 | 11793 | 0.07 | Why? |
| Tuberculosis | 1 | 2020 | 2895 | 0.07 | Why? |
| Mortality | 1 | 2021 | 7132 | 0.07 | Why? |
| Europe | 4 | 2021 | 12702 | 0.06 | Why? |
| SARS Virus | 5 | 2006 | 13021 | 0.06 | Why? |
| Seasons | 2 | 2015 | 4071 | 0.06 | Why? |
| Patient Acceptance of Health Care | 1 | 2020 | 5002 | 0.05 | Why? |
| Bayes Theorem | 2 | 2020 | 3237 | 0.05 | Why? |
| Syria | 1 | 2021 | 170 | 0.05 | Why? |
| Malawi | 1 | 2021 | 287 | 0.05 | Why? |
| Epidemics | 1 | 2021 | 6407 | 0.05 | Why? |
| Virus Replication | 1 | 2002 | 14331 | 0.05 | Why? |
| Population Surveillance | 3 | 2021 | 4967 | 0.05 | Why? |
| Disease Outbreaks | 6 | 2020 | 27595 | 0.05 | Why? |
| Commerce | 1 | 2009 | 1109 | 0.05 | Why? |
| Models, Statistical | 3 | 2020 | 5312 | 0.05 | Why? |
| Epidemiologic Methods | 1 | 2003 | 392 | 0.05 | Why? |
| Mosquito Nets | 1 | 2017 | 7 | 0.05 | Why? |
| Equipment and Supplies, Hospital | 1 | 2021 | 272 | 0.05 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.05 | Why? |
| Mosquito Control | 1 | 2020 | 237 | 0.04 | Why? |
| Virulence Factors | 1 | 2020 | 338 | 0.04 | Why? |
| Models, Biological | 3 | 2017 | 4907 | 0.04 | Why? |
| CD4 Lymphocyte Count | 1 | 2002 | 1517 | 0.04 | Why? |
| Tanzania | 1 | 2017 | 294 | 0.04 | Why? |
| Indonesia | 1 | 2021 | 1022 | 0.04 | Why? |
| Syndrome | 1 | 2021 | 1310 | 0.04 | Why? |
| Quarantine | 3 | 2020 | 18418 | 0.04 | Why? |
| Critical Care Nursing | 1 | 2021 | 469 | 0.04 | Why? |
| Public Health Practice | 1 | 2003 | 945 | 0.03 | Why? |
| Incidence | 4 | 2021 | 25622 | 0.03 | Why? |
| Hospitalization | 3 | 2020 | 54280 | 0.03 | Why? |
| Hospital Bed Capacity | 1 | 2021 | 1300 | 0.03 | Why? |
| China | 5 | 2021 | 50654 | 0.03 | Why? |
| Government | 1 | 2021 | 1453 | 0.03 | Why? |
| Aged | 5 | 2021 | 215776 | 0.03 | Why? |
| Double-Blind Method | 1 | 2002 | 5988 | 0.03 | Why? |
| Family Characteristics | 1 | 2021 | 2551 | 0.03 | Why? |
| Hong Kong | 3 | 2004 | 3361 | 0.03 | Why? |
| Needs Assessment | 1 | 2020 | 2352 | 0.03 | Why? |
| Survival Rate | 2 | 2021 | 9206 | 0.03 | Why? |
| Communicable Disease Control | 4 | 2021 | 29620 | 0.02 | Why? |
| Basic Reproduction Number | 1 | 2020 | 2676 | 0.02 | Why? |
| Immunization Programs | 1 | 2021 | 2006 | 0.02 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.02 | Why? |
| Drug Combinations | 1 | 2017 | 3852 | 0.02 | Why? |
| Republic of Korea | 1 | 2020 | 5858 | 0.02 | Why? |
| Adult | 6 | 2020 | 244371 | 0.02 | Why? |
| State Medicine | 1 | 2020 | 2847 | 0.02 | Why? |
| Cross-Sectional Studies | 2 | 2015 | 53120 | 0.02 | Why? |
| Child, Preschool | 3 | 2020 | 36283 | 0.02 | Why? |
| Germany | 1 | 2021 | 9196 | 0.02 | Why? |
| Databases, Factual | 1 | 2020 | 6248 | 0.02 | Why? |
| France | 1 | 2021 | 12074 | 0.02 | Why? |
| Immunoglobulin G | 2 | 2006 | 21571 | 0.02 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.02 | Why? |
| Virus Diseases | 1 | 2020 | 3779 | 0.02 | Why? |
| Child | 4 | 2020 | 70012 | 0.02 | Why? |
| Elective Surgical Procedures | 1 | 2020 | 5338 | 0.01 | Why? |
| Consensus | 1 | 2017 | 6345 | 0.01 | Why? |
| Stochastic Processes | 1 | 2003 | 369 | 0.01 | Why? |
| Viral Load | 1 | 2002 | 15850 | 0.01 | Why? |
| Disease Transmission, Infectious | 2 | 2020 | 9044 | 0.01 | Why? |
| Infant | 2 | 2020 | 30274 | 0.01 | Why? |
| Female | 5 | 2017 | 380317 | 0.01 | Why? |
| Treatment Outcome | 2 | 2017 | 51732 | 0.01 | Why? |
| Likelihood Functions | 1 | 2003 | 719 | 0.01 | Why? |
| Social Isolation | 1 | 2020 | 5932 | 0.01 | Why? |
| Prevalence | 2 | 2017 | 25773 | 0.01 | Why? |
| Animals | 1 | 2009 | 78931 | 0.01 | Why? |
| Geography | 1 | 2006 | 1801 | 0.01 | Why? |
| Probability | 1 | 2003 | 923 | 0.01 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.01 | Why? |
| Middle Aged | 3 | 2020 | 270681 | 0.01 | Why? |
| Male | 4 | 2009 | 367725 | 0.01 | Why? |
| History, 21st Century | 1 | 2004 | 1849 | 0.01 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.01 | Why? |
| Italy | 1 | 2021 | 38444 | 0.01 | Why? |
| Adolescent | 3 | 2020 | 86841 | 0.01 | Why? |
| Health Personnel | 2 | 2021 | 29646 | 0.01 | Why? |
| Cluster Analysis | 1 | 2003 | 3001 | 0.01 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.01 | Why? |
| RNA, Viral | 1 | 2002 | 32276 | 0.01 | Why? |
| Age Distribution | 1 | 2003 | 3567 | 0.01 | Why? |
| United States | 1 | 2020 | 46150 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Antibody Formation | 1 | 2006 | 4038 | 0.01 | Why? |
| Blood Donors | 1 | 2006 | 2956 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2004 | 51949 | 0.01 | Why? |
| Seroepidemiologic Studies | 1 | 2006 | 10017 | 0.01 | Why? |
| Communicable Diseases, Emerging | 1 | 2004 | 2523 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.01 | Why? |
| Patient Isolation | 1 | 2003 | 3182 | 0.01 | Why? |
| Disease Progression | 1 | 2003 | 13580 | 0.00 | Why? |
| Age Factors | 1 | 2004 | 21039 | 0.00 | Why? |
| Cross Infection | 1 | 2003 | 8675 | 0.00 | Why? |
| Time Factors | 1 | 2004 | 31397 | 0.00 | Why? |
| Infection Control | 1 | 2003 | 23131 | 0.00 | Why? |
Ghani's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(138)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(193)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_